ML Bio Solutions, Inc.

ACTIVE

北卡罗来纳州, United Stateswww.mlbiosolutions.comSubsidiary

Part of BridgeBio Pharma

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

50.0%

Phase 2

25.0%

Trial Status Distribution

Active, not recruiting

75.0%

Completed

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9

Phase 3

Active, not recruiting

interventional

Jun 2026107 participants

Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)

Phase 3

Active, not recruiting

interventional

May 2023112 participants

Study of BBP-418 in Patients With LGMD2I

Phase 2

Active, not recruiting

interventional

Feb 202114 participants

Biomarker Development in LGMD2i

Completed

observational

Dec 2019101 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations